A gene expression study of Haemophilus ducreyi identified the hypothetical lipoprotein HD0192, renamed here "fibrinogen binder A" (FgbA), as being preferentially expressed in vivo. To test the role played by fgbA in virulence, an isogenic fgbA mutant (35000HPfgbA) was constructed using H. ducreyi 35000HP, and 6 volunteers were experimentally infected with 35000HP or 35000HPfgbA. The overall pustule-formation rate was 61.1% at parent sites and 22.2% at mutant sites (P ‫؍‬ .019). Papules were significantly smaller at mutant sites than at parent sites (13.3 vs. 37.9 mm 2 ; P ‫؍‬ .002) 24 h after inoculation. Thus, fgbA contributed significantly to the virulence of H. ducreyi in humans. In vitro experiments demonstrated that fgbA encodes a fibrinogen-binding protein; no other fibrinogen-binding proteins were identified in 35000HP. fgbA was conserved among clinical isolates of both class I and II H. ducreyi strains, supporting the finding that fgbA is important for H. ducreyi infection.
Haemophilus ducreyi is the causative agent of chancroid, a genital ulcer disease that contributes to the spread of HIV-1 in areas of endemicity in the developing world [1] . H. ducreyi enters the body through microabrasions that occur during intercourse and primarily remains confined to the skin, where the organism resides extracellularly in a milieu of professional phagocytes [2, 3] . H. ducreyi colocalizes with fibrin, collagen, neutrophils, and macrophages during the papular, pustular, and ulcerative stages of disease, both in a human infection model and in naturally occurring chancroid [4, 5] .
A limited number of H. ducreyi virulence factors have been identified. Consistent with the organism's extracellular lifestyle and colocalization with collagen, full virulence of H. ducreyi in humans requires expression of the collagen-specific adhesin NcaA, the antiphagocytic proteins LspA1 or LspA2, and 2 outer membrane proteins (OMPs), DsrA and DltA, that confer protection from serum-mediated killing [6 -9] . Other virulence factors of H. ducreyi required for human infection include the hemoglobin receptor HgbA; the peptidoglycanassociated lipoprotein PAL, which is involved in outer membrane stability; an intact Flp locus, which encodes fimbria-like proteins and type IV-like secretory proteins; and a locus encoding enterobacterial common antigen-like biosynthetic proteins [10 -13] .
With the goal of discovering new H. ducreyi virulence factors, we identified a panel of H. ducreyi genes whose corresponding mRNAs are preferentially expressed in experimental pustules [14] . The in vivo-expressed genes included 133 open reading frames (ORFs) encoding proteins of unknown function [14] . We performed in silico analyses of these in vivo-expressed hypothetical proteins, including subcellular localization algorithms and searches for conserved motifs, domains, and structural features [15] [16] [17] [18] [19] [20] . From these analyses, we identified 7 hypothetical OMPs (M.E.B., unpublished data). In the present study, we used the human model of H. ducreyi infection to examine the role played by one such protein, the hypothetical lipoprotein HD0192, in the virulence of H. ducreyi. We also explored a putative role for HD0192 in binding to fibrinogen (Fg); on the basis of these experiments, we renamed the protein "Fg binder A" (FgbA). (table 1) were cultured at 33°C, using media described elsewhere [27] . Escherichia coli TOP10 (Invitrogen) was used for cloning, and B21 DE3/pLysS (Invitrogen) was used for protein expression. A recombinant clone expressing the 36-kDa Fg-binding domain of Staphylococcus aureus ClfA in E. coli was provided by M. Höök (Texas A&M Health Science Center) [28] . E. coli strains were cultured using Luria-Bertani agar or broth supplemented with kanamycin (50 g/mL) or ampicillin (50 g/mL).
METHODS

Bacterial strains and growth conditions. H. ducreyi strains
Construction and complementation of an fgbA mutant. A map of the fgbA-containing locus in 35000HP is shown in figure   1A . The upstream and downstream ORFs, HD0193 and HD0191, were predicted to be transcribed from the opposite strand as fgbA, suggesting that fgbA was monocistronic ( figure  1A) . A 4.1-kb fragment containing HD0192 (fgbA) was amplified by polymerase chain reaction (PCR) from 35000HP genomic DNA (see table 2 for primers). The amplicons were digested with BamHI and XbaI and cloned into pBluescript II SKϩ (Stratagene). A kanamycin-resistance (KanR) cassette from pUC18K [29] was inserted into the cloned fgbA ORF; the mutated fgbA was subcloned into pRSM2072, which expresses lacZ and acts as a suicide vector in H. ducreyi [30] , and introduced into H. ducreyi 35000HP by electroporation. KanR transformants were propagated in medium containing 5-bromo-4-chloro-3-indoyl-␤-D-galactopyranoside (X-gal), as described elsewhere [30] , to identify colonies that had undergone allele exchange. One such colony was designated 35000HPfgbA. The fgbA mutation in 35000HPfgbA was confirmed by sequencing, Southern blotting, and PCR analyses (data not shown). 35000HP and 35000HPfgbA had similar OMP and lipooligosaccharide (LOS) profiles, assessed as described elsewhere [11] , and demonstrated similar growth rates in broth (data not shown). For complementation, the fgbA ORF and 197 bp of upstream flanking sequence was amplified by PCR (table 2) and cloned into the shuttle vector pLSKS [31] . The resulting construct was introduced into 35000HPfgbA by electroporation and selected on plates containing kanamycin and streptomycin.
Human inoculation protocol. Six healthy volunteers (5 men and 1 woman; 5 whites and 1 black; age range, 21-54 years; mean Ϯ SD age, 32 Ϯ 14) were recruited for the study. Subjects gave informed consent for participation and HIV serology, in accordance with the human experimentation guidelines of the US Department of Health and Human Services and the Institutional Review Board of Indiana University-Purdue University of Indianapolis. All aspects of the mutant-parent trial and determination of colony phenotypes were performed exactly as described elsewhere [7, 10, 13] . Statistical analysis compared papule-and pustule-formation rates using a logistical regression model with generalized estimating equations to adjust for within-subject correlation, as described elsewhere [12] . Papule size was compared between strains by means of a mixed effects model with a random-subject effect.
Recombinant fusion protein construction and expression. Genes encoding HD0192, HD0581, and HD1218 were amplified by PCR (table 2) starting immediately downstream of their lipidation sites, cloned into pCR-XL-TOPO (Invitrogen), and subcloned into pRSET B (Invitrogen) to express the ORFs fused in frame with an N-terminal 6ϫHis tag. The constructs were expressed in B21 DE3/pLysS, in accordance with the manufacturer's directions. Recombinant proteins were purified with the QIAexpressionist System (Qiagen), in accordance with the manufacturer's instructions.
Fg-binding ligand blot assay. Purified human Fg (Enzyme Research Laboratories) was labeled with digoxigenin (dig) using the DIG protein labeling kit from Roche Applied Sciences, in accordance with the manufacturer's instructions. Bacterial proteins were separated by SDS-PAGE, transferred to polyvinylidene fluoride (PVDF) membranes, blocked with 2% nonfat milk in PBS (pH 7.4), and probed with a 1:1000 dilution of dig-Fg (10 g/mL) in 2% milk-PBS overnight. dig-Fg was detected using digoxigenin detection reagents (Roche), in accordance with the manufacturer's protocols.
Bacterial protein preparations. Whole-cell lysates and OMPs of 35000HP were prepared as described elsewhere [27] . Triton X-114 phase partitioning was performed on midlogarithmic cultures of 35000HP, as described elsewhere [32] . Following separation, both phases were precipitated with acetone to collect proteins. Aqueous-and detergent-phase protein samples were suspended in identical volumes of Laemmli sample buffer for comparison by standard SDS-PAGE or in rehydration buffer containing 9 mol/L urea, 4% Igepal CA-630, 1% dithiothreitol, and 2% carrier ampholytes (pH 4 -7) [33] for 2-dimensional gel electrophoresis (2DE).
2DE and tandem mass spectrometry (MS-MS).
2DE was performed by the Indiana Center for Applied Protein Sciences, as described elsewhere [33, 34] . Briefly, detergent-phase proteins from 35000HP were separated by isoelectric focusing with a pH 4 -7 linear gradient, followed by separation on the basis of molecular size through 4%-20% gradient gels (Bio-Rad). Samples were analyzed in parallel on 2 gels; one gel was stained with Coomassie dye [34] , and the other was transferred to PVDF and probed with dig-Fg by ligand blot. Coomassie-stained spots corresponding to positive signals in the ligand blot were excised and subjected to MS-MS for peptide sequence analysis. The results indicated multiple proteins in each spot; proteins with at least 2 distinct matching peptides were considered for further analysis (table 3) . Conservation of fgbA sequence in H. ducreyi strains. H. ducreyi strains and class designations are listed in table 1. For strains whose phenotypic class had not been previously reported, we amplified by PCR the dsrA locus from genomic DNA by means of the class-specific primer pairs described by White et al. (table 2 and [24] ). All strains tested contained a dsrA locus that amplified with class I-specific but not class II-specific primers (data not shown) and were therefore considered class I strains (table 1) .
fgbA-containing sequences, including 145 bp 5' and 130 bp 3' to the fgbA ORF, were amplified by PCR from genomic DNA of all listed H. ducreyi strains (table 2). The amplicons were sequenced, and the resulting sequences aligned by means of the ClustalW algorithm in the Lasergene software package (version 7; DNASTAR).
RESULTS
Contribution of fgbA to virulence in the human model of infection. fgbA transcripts are expressed during human infection [14] . To determine whether FgbA plays a role in disease, fgbA was inactivated in H. ducreyi 35000HP by insertion of a KanR cassette ( figure 1A) . The resulting mutant, 35000HPfgbA, was directly compared with 35000HP for virulence in the human model of H. ducreyi infection. Six healthy adults volunteered for the study (table 4). In the first iteration, each of 2 subjects was inoculated with a fixed estimated delivered dose (88 cfu) of 35000HP at 3 sites on one arm and varying estimated delivered doses (59, 118, and 256 cfu) of 35000HPfgbA at 3 sites on the other arm. Pustules formed at 3 of 6 parent sites and at 1 of 6 mutant sites (table 4). In the second iteration, 3 volunteers were inoculated with 98 cfu of 35000HP on one arm and 43, 85, and 169 cfu of 35000HPfgbA on the other arm. Pustules formed at 5 of 9 parent sites and at 3 of 9 mutant sites (table 4). In the third iteration, the volunteer was inoculated with 50 cfu of 35000HP at 3 sites and 78 cfu of 35000HPfgbA at 3 sites; pustules formed at all 3 parent sites and at 0 of 3 mutant sites.
Overall, the pustule-formation rate was 61.1% (95% confidence interval [CI], 32.7%-89.6%) at 18 parent sites and 22.2% (95% CI, 0.1%-51.7%) at 18 mutant sites (P ϭ .019). Papules were significantly smaller at mutant sites (mean, 13.3 mm 2 ) than at parent sites (mean, 37.9 mm 2 ) 24 h after inoculation (P ϭ .002). These results suggested that expression of FgbA facilitates the ability of H. ducreyi to initiate disease and progress to pustule formation in humans.
For the parent and mutant broth cultures used to prepare the inocula, all 107 parent and 107 mutant colonies tested were phenotypically correct for resistance to kanamycin. Ten (67.7%) of 15 sites inoculated with the parent yielded positive surface cultures, whereas 2 (13.3%) of 15 mutant sites yielded a positive surface culture. All colonies obtained from surface cultures (n ϭ 406 and n ϭ 43) and biopsy specimens (n ϭ 72 and n ϭ 36) from parent sites and mutant sites, respectively, had the expected antibiotic susceptibility.
Binding of recombinant FgbA to human Fg. To discern possible functions for FgbA, we performed in silico analysis of the deduced protein sequence (figure 1B). The N-terminus contained a signal II peptide and lipidation site consistent with a lipoprotein ( figure 1B) . The C-terminus contained 3.5 direct tandem repeats of a 29-aa motif with a consensus sequence of N-EMKDAAKAKLEDMKESAAEAKESLAEKAN-C. The repetitive region was predicted to form an ␣-helical coiled-coil structure (figure 1B). Coiled-coil motifs are found in a wide variety of proteins with structural or regulatory functions and frequently involve homomeric or heteromeric protein-protein interactions [18] . Several bacterial proteins with coiled coils interact with host proteins [35] [36] [37] . The only known host protein that H. ducreyi colocalizes with-and for which no adhesin has yet been identified-is fibrin. Many bacteria interact with fibrin via Fgbinding proteins with coiled-coil motifs. Thus, we hypothesized that FgbA may bind to Fg.
To determine whether FgbA could bind to Fg, the fgbA ORF was expressed, without its signal peptide, as a recombinant N-terminal 6ϫHis-tagged fusion protein (designated r-FgbA) and probed with dig-Fg in a ligand blot assay. The Fg-binding domain of ClfA from Staphylococcus aureus served as a positive control [28] . As shown in figure 2A , r-FgbA demonstrated Fgbinding activity, both within an E. coli whole-cell lysate ( figure  2A, lane 2) and after purification over a nickel column ( figure  2A, lane 3) . These data suggested that FgbA was able to bind to human Fg.
Identification of Fg-binding protein(s) in H. ducreyi. Because many pathogens express redundant adhesins for important ligands, we examined 35000HP for additional Fg-binding proteins by the ligand blot assay. We first probed whole-cell ly- sates and OMP preparations of H. ducreyi 35000HP with dig-Fg. As shown in figure 2B , dig-Fg bound to a single ϳ18-kDa band present in whole-cell lysates and in OMPs.
To partially purify the Fg-binding protein, H. ducreyi 35000HP cells were subjected to Triton X-114 phase partitioning ( figure 2C ). Fg-binding activity partitioned to the detergent phase; no activity was observed in the aqueous phase ( figure 2C) . Thus, the Fg-binding activity was likely due to a protein with hydrophobic domains or components.
To identify the Fg-binding band, detergent-phase proteins were separated by 2DE and subjected to ligand blot analysis. Two Fg-binding spots were detected by ligand blot; each migrated to the same molecular size and slightly different isoelectric points (pIs) (in the range of 4.0 -5.5 [data not shown]), suggesting one protein with heterogeneous posttranslational modification. Coomassie-stained spots corresponding to the Fg-binding spots were excised and subjected to MS-MS analysis. Peptides were identified that corresponded to 7 proteins, each with a predicted molecular weight between 10 and 20 kDa and acidic pIs (table 3) . One of the proteins identified was FgbA (table 3) . Two additional identified proteins, lipoprotein HlpB and hypothetical protein HD1218, had no known function; the remaining 4 proteins were orthologous to bacterial proteins with assigned functions (table 3) . Three of the proteins, including FgbA, lipoprotein HlpB, and hypothetical protein HD1218, contained predicted signal peptides, indicating an extracytoplasmic location [15, 16] ; the remaining 4 proteins were predicted to be cytoplasmic (table 3) .
To determine whether HlpB or HD1218 was able to bind to Fg, the genes corresponding to both proteins were recombinantly expressed as N-terminal 6ϫHis-tagged fusion proteins and subjected to ligand blot analysis. Neither recombinant HlpB nor recombinant HD1218 bound to dig-Fg in the ligand blot assay (data not shown). Thus, FgbA was the only H. ducreyi OMP identified by ligand blot to bind to human Fg. The predicted lipidation of FgbA was consistent with the hydrophobic nature and heterogeneous pI observed for the Fg-binding activity in H. ducreyi.
Lack of Fg binding activity by a fgbA mutant. To confirm that fgbA conferred H. ducreyi binding to Fg by ligand blot, we compared 35000HP and 35000HPfgbA for Fg binding. 35000HPfgbA did not express the 18-kDa Fg-binding protein; however, trans-complementation with the fgbA ORF restored Fg-binding activity to the mutant ( figure 2D ). The complemented mutant showed a much stronger Fg-binding band than did the parent strain. Although FgbA levels in 35000HP and the complemented mutant have not been quantitatively compared, the increased activity is likely the result of overexpression of fgbA on the multicopy shuttle vector. The mutagenesis and complementation data demonstrate that fgbA encodes the H. ducreyi Fg-binding protein detected by ligand blot.
Conservation of
on the basis of differences in OMP and LOS migration patterns [24] . To examine the conservation of fgbA among strains of both classes, we amplified by PCR the fgbA locus from 10 clinical H. ducreyi isolates, including 6 class I and 4 class II strains (table 1) . fgbAcontaining amplicons were obtained from all strains; however, amplicons from 6 strains migrated faster than that from 35000HP, indicating size variations in the fgbA loci ( figure 3A) . Sequencing showed that the faster-migrating amplicons contained deletions within the repetitive motif of fgbA; however, no strains harbored frameshift mutations or premature stop codons ( figure 3B ).
Class-specific changes were noted among the sequenced fgbA loci. Compared with fgbA of 35000HP, 3 class I strains had identical fgbA ORFs, and 2 strains contained a 58-aa deletion but were otherwise identical ( figure 3B ). This deletion removed the first 2 copies of the 29-aa repeat in 35000HP FgbA (figure 1B). No class I loci had changes in the sequenced regions outside the ORF (data not shown).
The 4 class II isolates tested were identical to each other, and all contained the same 58-aa deletion observed in 2 of the class I strains ( figure 3B ). However, compared with the class I fgbA ORFs, the class II ORFs harbored 2 conservative amino acid substitutions and a 7-aa insertion ( figure 3B) . Upstream of the ORF, the class II strains harbored a 1-bp deletion (data not shown). Although this deletion did not affect the predicted promoter elements of fgbA, it did produce a frameshift mutation in the 5' gene, HD0193. The class II strains also harbored a T3 C base change 98 bp downstream of the 3' end of the fgbA ORF that was outside the predicted Rho-independent terminator and HD0191 ( figure 1A) . Overall, the fgbA ORF was conserved among class I and II strains of H. ducreyi but with differences in the length of the repetitive motif.
DISCUSSION
In the present study, we identified a novel Fg-binding protein, FgbA, that contributes significantly to the disease process of H. ducreyi infection in human volunteers. We originally identified fgbA among H. ducreyi transcripts expressed during human infection [14] , and, because of its predicted outer membrane location, we hypothesized that FgbA is involved in virulence. Using the human model of H. ducreyi infection, we demonstrated that an isogenic fgbA mutant, although able to cause pustules, did so at a significantly lower rate than that of 35000HP; thus, 35000HPfgbA was partially attenuated [9, 13] . Biosafety considerations preclude testing a trans-complemented mutant in human subjects because of potential horizontal transfer of resistance plasmids to skin flora. With this caveat, the human challenge experiments demonstrate that FgbA is important for the organism's virulence.
Our in vitro assays sought to identify a function for this novel virulence factor. The predicted coiled-coil structure suggested that FgbA may interact with host proteins. H. ducreyi colocalizes with collagen and fibrin in vivo, and a collagen-specific adhesin has already been identified in H. ducreyi [4 -6] . We therefore tested the ability of FgbA to bind to Fg, the soluble precursor of fibrin. r-FgbA bound to Fg, and FgbA was subsequently identified as the major H. ducreyi protein binding to Fg in the ligand blot assay. Although FgbA bears no sequence homology with other known Fg-binding proteins, several other extracellular pathogens, including Staphylococcal and Streptococcal species, express Fg-binding proteins with coiled-coil and repetitive motifs [38 -40] . Another notable feature of FgbA is the number of charged residues, which represent 45% of the mature peptide and confer a net charge of Ϫ7. Charged residues frequently indicate sites of protein-protein interaction; however, the large number of charges in FgbA is unusual. The role played by these charged residues in interactions with Fg is being investigated.
The predicted outer membrane location of FgbA was based on sorting rules for E. coli lipoproteins, since lipoprotein sorting has not been well studied in H. ducreyi [17, 19, 20] . Consistent with an outer membrane location, Fg-binding activity was observed in sarkosyl-insoluble protein preparations, which are enriched for OMPs ( figure 2B) ; however, this is not proof of outer membrane location. Furthermore, even if anchored to the outer membrane by its lipid portion, the protein portion of FgbA could face either the periplasm or the external milieu. Thus, additional work is needed to determine the location and possible surface exposure of FgbA. The fgbA-containing locus is conserved among class I and II strains of H. ducreyi. Although the strains differed in the lengths of their ORFs, all strains maintained an intact fgbA ORF. This conservation among clinical isolates supports the conclusion that fgbA is important for H. ducreyi. The major difference in the deduced FgbA sequences was the length of the repetitive coiledcoil region. Despite the smaller size, the strains with deletions relative to 35000HP were still predicted to form coiled coils. Whether these deletions or the class II-specific amino acid changes affect the capacity to bind to Fg is under investigation.
A BLASTP (version 2.2.19) search with FgbA or its 29-aa repetitive motif showed homology with hypothetical proteins in several members of the Pasteurellaceae family, including Actinobacillus pleuropneumoniae Aple 020001366, Haemophilus somnus HS1338, Pasteurella multocida PM0442, and NTHI1667 from nontypeable Haemophilus influenzae 86-028NP. All 4 homologs are predicted lipoproteins of 15-22 kDa with a pI of 4.6 -4.9 containing a disproportionate number of charged amino acids and a net negative charge. The C-terminal portions of these homologs encoded 3-5 direct tandem repeats of 22-29 aa. Thus, FgbA may represent a family of lipidated virulence factors in several pathogenic genera of the Pasteurellaceae.
What role might FgbA play in H. ducreyi infection? Although not a component of normal skin, Fg transudates from serum into H. ducreyi-infected lesions and is cleaved to form a matrix of fibrin strands. Fg and fibrin are plentiful in H. ducreyi-infected lesions throughout the disease process [4, 5] . Thus, FgbA may act as an adhesin to anchor the bacterium to the fibrin matrix. Although the ligand blot assay used in the present study does not define FgbA as an adhesin, the assay demonstrated that FgbA can bind to Fg.
One alternative role of Fg-binding proteins in pathogenesis is to protect extracellular bacteria from phagocytosis, as exemplified by Streptococcus pyogenes M protein [39, 41] . Another possible role of Fg-binding proteins is to occlude opsonization with antibodies or complement, although this function is controversial [42] [43] [44] [45] . Because H. ducreyi associates with Fg in vivo and resists phagocytosis, we hypothesize that FgbA may be involved in adherence or antiphagocytic activity of H. ducreyi. Studies to detail the mechanism(s) by which FgbA contributes to virulence in vivo are under way.
